ω-Transaminase Engineering for Aminated Aliphatic Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The in vivo biosynthesis of carbon-based products using transamination reactions catalyzed by ω-transaminases is limited by equilibrium thermodynamics, product inhibition, and poor substrate tolerance, hindering the production of aminated aliphatic compounds with carbon chain lengths of C5-C19.

Innovation Solution

Altering the reaction conditions of transamination reactions catalyzed by ω-transaminases, including amino acid substitutions and changes in substrate specificity, to enhance the production of aminated aliphatic compounds like 7-AHA and 6-aminohexanoic acid, by optimizing the enzymatic activity and substrate specificity of ω-transaminases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If transamination reactions are used for in vivo biosynthesis of carbon-based products, then biochemical pathways can be constructed to produce aminated aliphatic compounds, but equilibrium thermodynamics limits the reaction efficiency and product yield

Engineering Contradiction:
Improveproduction efficiency of aminated aliphatic compoundsVSAvoidreaction equilibrium limitation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying reaction conditions including pH, temperature, and substrate concentration to shift the equilibrium position of transamination reactions. It also employs amino acid substitutions in the ω-transaminase enzyme to alter catalytic properties and improve reaction efficiency, directly addressing the equilibrium thermodynamics limitation.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If ω-transaminase is used to catalyze transamination reactions, then aminated aliphatic compounds can be produced, but product inhibition reduces the overall yield

Engineering Contradiction:
Improveproduct yield of aminated aliphatic compoundsVSAvoidproduct inhibition
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent employs product removal strategies by extracting the aminated aliphatic compound products from the reaction system continuously or periodically. This prevents product accumulation and reduces product inhibition effects on the ω-transaminase enzyme, thereby maintaining higher reaction rates and improving overall product yield.

Inventive Principle:
Principle #2Taking out (Extraction)

3Adaptability or versatility

If transamination reactions are implemented in vivo, then biosynthetic pathways can be established, but poor substrate tolerance of ω-transaminase limits the scope of producible compounds

Engineering Contradiction:
Improvesubstrate specificity rangeVSAvoidsubstrate tolerance
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent achieves universality by engineering ω-transaminase enzymes with broad substrate specificity through amino acid substitutions. The modified enzymes can catalyze transamination reactions with various substrates including different chain length fatty acid derivatives, enabling production of multiple aminated aliphatic compounds (C5-C19) from a single enzyme system.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Increases the yield of aminated aliphatic compounds by enhancing enzymatic activity and substrate specificity, leading to improved production efficiencies and product yields.

Implementation Method 1

ω-TAMs are key enzymes that catalyze the conversion of substrates into products, for example, the conversion of pimelate semialdehyde into 7-AHA, using an amino donor, by catalyzing the exchange of the keto group (═O) on the pimelate semialdehyde with an amine group (NH2).

Methodology Applied
Scientific EffectTransamination reaction: Chemical Bonding

Data Source

PatentUS11203771B2Materials and methods for biosynthetic manufacture of carbon-based chemicals
Publication Date: 2021.12.21 INV NYLON CHEMICALS AMERICAS LLC
  • US11203771B2 patent drawing
  • US11203771B2 patent drawing
  • US11203771B2 patent drawing

AI summary

This disclosure relates to strategies for in vivo production of certain carbon-based products, for example, aminated aliphatic compounds having a carbon chain length of C5-C19.